Wassmann C, Hellberg A, Tannich E, Bruchhaus I
Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany.
J Biol Chem. 1999 Sep 10;274(37):26051-6. doi: 10.1074/jbc.274.37.26051.
To obtain insight into the mechanism of metronidazole resistance in the protozoan parasite Entamoeba histolytica, amoeba trophozoites were selected in vitro by stepwise exposures to increasing amounts of metronidazole, starting with sublethal doses of 4 microM. Subsequently, amoebae made resistant were able to continuously multiply in the presence of a 40 microM concentration of the drug. In contrast to mechanisms of metronidazole resistance in other protozoan parasites, resistant amoebae did not substantially down-regulate pyruvate:ferredoxin oxidoreductase or up-regulate P-glycoproteins, but exhibited increased expression of iron-containing superoxide dismutase (Fe-SOD) and peroxiredoxin and decreased expression of flavin reductase and ferredoxin 1. Episomal transfection and overexpression of the various antioxidant enzymes revealed significant reduction in susceptibility to metronidazole only in those cells overexpressing Fe-SOD. Reduction was highest in transfected cells simultaneously overexpressing Fe-SOD and peroxiredoxin. Although induced overexpression of Fe-SOD did not confer metronidazole resistance to the extent found in drug-selected cells, transfected cells quickly adapted to constant exposures of otherwise lethal metronidazole concentrations. Moreover, metronidazole selection of transfected amoebae favored retention of the Fe-SOD-containing plasmid. These results strongly suggest that peroxiredoxin and, in particular, Fe-SOD together with ferredoxin 1 are important components involved in the mechanism of metronidazole resistance in E. histolytica.
为深入了解原生动物寄生虫溶组织内阿米巴对甲硝唑耐药的机制,通过逐步增加甲硝唑的用量在体外对阿米巴滋养体进行筛选,起始剂量为亚致死剂量4微摩尔。随后,获得耐药性的阿米巴能够在40微摩尔浓度的该药物存在下持续增殖。与其他原生动物寄生虫对甲硝唑的耐药机制不同,耐药阿米巴并未显著下调丙酮酸:铁氧化还原蛋白氧化还原酶或上调P-糖蛋白,而是表现出含铁超氧化物歧化酶(Fe-SOD)和过氧化物酶体增殖物激活受体表达增加,黄素还原酶和铁氧化还原蛋白1表达降低。对各种抗氧化酶进行游离型转染和过表达后发现,仅在过表达Fe-SOD的细胞中对甲硝唑的敏感性显著降低。在同时过表达Fe-SOD和过氧化物酶体增殖物激活受体的转染细胞中降低最为明显。尽管诱导过表达Fe-SOD并未使细胞获得与药物筛选细胞中相同程度的甲硝唑耐药性,但转染细胞能迅速适应持续暴露于原本致死浓度的甲硝唑环境。此外,对转染的阿米巴进行甲硝唑筛选有利于保留含Fe-SOD的质粒。这些结果有力地表明,过氧化物酶体增殖物激活受体,特别是Fe-SOD与铁氧化还原蛋白1一起是参与溶组织内阿米巴对甲硝唑耐药机制的重要成分。